Troponin T measurements by high-sensitivity vs conventional assays for risk stratification in acute dyspnea.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Clinical Chemistry

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1373/clinchem.2011.175976PMID 22100806
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Minor elevations in troponin I are associated with mortality and adverse cardiac events in patients with atrial fibrillation.

  2011cited by this paper
• The GRACE score's performance in predicting in-hospital and 1-year outcome in the era of high-sensitivity cardiac troponin assays and B-type natriuretic peptide

  2011cited by this paper
• The 10 commandments of troponin, with special reference to high sensitivity assays

  2011cited by this paper
• Association between high-sensitivity cardiac troponin T levels and the predicted cardiovascular risk in middle-aged men without overt cardiovascular disease.

  2010cited by this paper
• Highly sensitive troponin T assay in normotensive patients with acute pulmonary embolism.

  2010cited by this paper
• Analytical validation of a high-sensitivity cardiac troponin T assay.

  2010cited by this paper
• Over time, high-sensitivity TnT replaces NT-proBNP as the most powerful predictor of death in patients with dialysis-dependent chronic renal failure.

  2010cited by this paper
• Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults.

  2010cited by this paper
• Increases of cardiac troponin in conditions other than acute coronary syndrome and heart failure.

  2009cited by this paper
• Reference population and marathon runner sera assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and I assays.

  2009cited by this paper
• Criteria for Evaluation of Novel Markers of Cardiovascular Risk: A Scientific Statement From the American Heart Association

  2009cited by this paper
• Early diagnosis of myocardial infarction with sensitive cardiac troponin assays.

  2009cited by this paper
• A sensitive cardiac troponin T assay in stable coronary artery disease.

  2009cited by this paper
• Haemodialysis patients longitudinally assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and cardiac troponin I assays

  2009cited by this paper
• Cardiac troponin and outcome in acute heart failure.

  2008cited by this paper
• StAR: a simple tool for the statistical comparison of ROC curves

  2008cited by this paper
• Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond

  2008cited by this paper
• Universal definition of myocardial infarction.

  2007cited by this paper
• National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes.

  2007cited by this paper
• National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes.

  2007cited by this paper
• Long‐term prognostic value of B‐type natriuretic peptide in cardiac and non‐cardiac causes of acute dyspnoea

  2007cited by this paper
• Cardiac biomarkers and survival in haemodialysis patients

  2007cited by this paper
• Prognostic Value of Very Low Plasma Concentrations of Troponin T in Patients With Stable Chronic Heart Failure

  2007cited by this paper
• B-type natriuretic peptide and amino terminal proBNP predict one-year mortality in short of breath patients independently of the baseline diagnosis of acute destabilized heart failure.

  2006cited by this paper
• Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department.

  2006cited by this paper
• Prognostic Value of Troponin T and I Among Asymptomatic Patients With End-Stage Renal Disease: A Meta-Analysis

  2005cited by this paper
• Ongoing Myocardial Injury in Stable Severe Heart Failure: Value of Cardiac Troponin T Monitoring for High-Risk Patient Identification

  2004cited by this paper
• Cardiac troponin elevations in patients without acute coronary syndrome.

  2002cited by this paper
• Biochemical markers of cardiac damage: from traditional enzymes to cardiac-specific proteins. IFCC Subcommittee on Standardization of Cardiac Markers (S-SCM).

  1999cited by this paper
• Evaluation of the patient with shortness of breath: an evidence based approach.

  1999cited by this paper
• Pathophysiology of dyspnea.

  1995cited by this paper
• [Pathophysiology of dyspnea].

  1989cited by this paper
• Clinical Chemistry

  1884cited by this paper

• Quantifying Hemodynamic Cardiac Stress and Cardiomyocyte Injury in Normotensive and Hypertensive Acute Heart Failure

  2024cites this paper
• Cardiac Troponin T and NT-proBNP for Prediction of 30-Day Readmission or Death in Patients with Acute Dyspnea: Data from the Akershus Cardiac Examination 2 Study

  2023cites this paper
• Introduction of a high sensitivity troponin reduces ED length of stay.

  2023cites this paper
• 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

  2021cites this paper
• 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

  2021cites this paper
• 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

  2021cites this paper
• 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

  2021cites this paper
• Using High Sensitivity Troponins to Rule Out Acute Coronary Syndrome and Lower Admission Rates.

  2019cites this paper
• Prognostic implications of detectable cardiac troponin I below the 99th percentile in patients admitted to an emergency department without acute coronary syndrome

  2018cites this paper
• Evaluation of eight biomarkers to predict short-term mortality in patients with acute severe dyspnea.

  2017cites this paper
• EAHFE – TROPICA2 study. Prognostic value of troponin in patients with acute heart failure treated in Spanish hospital emergency departments

  2017cites this paper
• Cardiac Troponin T: Smaller Molecules in Patients with End-Stage Renal Disease than after Onset of Acute Myocardial Infarction.

  2017cites this paper
• High-sensitivity cardiac troponins in health and disease

  2016cites this paper
• High-sensitivity troponin assays for the early rule-out or diagnosis of acute myocardial infarction in people with acute chest pain: a systematic review and cost-effectiveness analysis.

  2015cites this paper
• Chief Complaint at Admission Relates to Troponin Level and Mortality in Patients With Non-ACS Troponin Elevation

  2015cites this paper
• Hochsensitives Troponin in Diagnostik, Risikostratifizierung und Prognose bei Patienten mit akuten kardiovaskulären Erkrankungen in der Notaufnahme

  2015cites this paper
• Novel approaches to the assessment of patients with chest symptoms in the acute medical and outpatient settings : the use of multislice computed tomography

  2015cites this paper
• High-sensitivity cardiac troponins in heart and kidney diseases: from lab to clinic

  2015cites this paper
• TnI-Ultra assay measurements in cancer patients: Comparison with the conventional assay and clinical implication

  2014cites this paper
• Effect of Antioxidant Supplementation on Exercise-Induced Cardiac Troponin Release in Cyclists: A Randomized Trial

  2013cites this paper
• High-sensitivity cardiac troponins: no more ‘negatives’

  2013cites this paper
• Biomarker Diagnostics in Acute Cardiac and Noncardiac Dyspnea: Is There a Role for Point-of-Care Testing?

  2013cites this paper
• High sensitivity troponin in cardiovascular disease. Is there more than a marker of myocardial death?

  2013cites this paper
• Troponin, the best there is!

  2012cites this paper
• Clinical Use and Measurement of Cardiac Troponin (cTn)

  2012cites this paper
• Impact of biomarkers, proteomics, and genomics in cardiovascular disease.

  2012cites this paper
• Multimarker strategy for short-term risk assessment in patients with dyspnea in the emergency department: the MARKED (Multi mARKer Emergency Dyspnea)-risk score.

  2012cites this paper